Clinical trials
Phase 1/2 Thyroid Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Effector Therapeutics | 1 |
| Hoffmann-La Roche | 1 |
| M.D. Anderson Cancer Center | 1 |
| Nantes University Hospital | 1 |
| Odense University Hospital | 1 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1 |
| Sun Yat-sen University | 1 |
| The Second People's Hospital of Huai'an | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Diseases | 12 |
| Endocrine System Diseases | 5 |
| Head and Neck Neoplasms | 5 |
| Neoplasms | 5 |
| Bronchial Neoplasms | 4 |
| Carcinoma, Bronchogenic | 4 |
| Carcinoma, Medullary | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Colonic Neoplasms | 4 |
| Endocrine Gland Neoplasms | 4 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.